Lipid raft microdomain compartmentalization of TC10 is required for insulin signaling and GLUT4 translocation. by Watson, RT et al.
UC San Diego
UC San Diego Previously Published Works
Title
Lipid raft microdomain compartmentalization of TC10 is required for insulin signaling and 
GLUT4 translocation.
Permalink
https://escholarship.org/uc/item/6xs9j18m
Journal
The Journal of cell biology, 154(4)
ISSN
0021-9525
Authors
Watson, RT
Shigematsu, S
Chiang, SH
et al.
Publication Date
2001-08-13
DOI
10.1083/jcb.200102078
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
 
 
 The Rockefeller University Press, 0021-9525/2001/08/829/12 $5.00
The Journal of Cell Biology, Volume 154, Number 4, August 20, 2001 829–840
http://www.jcb.org/cgi/doi/10.1083/jcb.200102078
JCB
 
Article
 
829
 
Lipid raft microdomain compartmentalization 
of TC10 is required for insulin signaling and 
GLUT4 translocation
 
Robert T. Watson,
 
1
 
 Satoshi Shigematsu,
 
1
 
 Shian-Huey Chiang,
 
2,3
 
 Silvia Mora,
 
1
 
 Makoto Kanzaki,
 
1
 
 
Ian G. Macara,
 
4
 
 Alan R. Saltiel,
 
3
 
 and Jeffrey E. Pessin
 
1
 
1
 
Department of Physiology and Biophysics, University of Iowa, Iowa City, IA 52242
 
2
 
Cellular and Molecular Biology Graduate Program, University of Michigan, Ann Arbor, MI 48109
 
3
 
Departments of Internal Medicine and Physiology, Life Sciences Institute, University of Michigan Medical Center, 
Ann Arbor, MI 48109
 
4
 
Center for Cell Signaling, University of Virginia, Charlottesville, VA 22908
 
ecent studies indicate that insulin stimulation of
glucose transporter (GLUT)4 translocation requires
at least two distinct insulin receptor–mediated sig-
nals: one leading to the activation of phosphatidylinositol
3 (PI-3) kinase and the other to the activation of the small
 
GTP binding protein TC10.
 
 
 
We now demonstrate that
TC10 is processed through the secretory membrane traf-
ficking system and localizes to caveolin-enriched lipid
raft microdomains. Although insulin activated the wild-
type TC10 protein and a TC10/H-Ras chimera that were
targeted to lipid raft microdomains, it was unable to acti-
vate a TC10/K-Ras chimera that was directed to the non-
R
 
lipid raft domains. Similarly, only the lipid raft–localized TC10/
H-Ras chimera inhibited GLUT4 translocation, whereas
the TC10/K-Ras chimera showed no significant inhibitory
 
activity. Furthermore, disruption of lipid raft microdo-
 
mains by expression of a dominant-interfering caveolin
3 mutant (Cav3/DGV) inhibited the insulin stimulation
of GLUT4 translocation and TC10
 
 
 
lipid raft localization
and activation without affecting PI-3 kinase signaling.
These data demonstrate that the insulin stimulation of
GLUT4 translocation in adipocytes requires the spatial
separation and distinct compartmentalization of the PI-3
kinase and TC10 signaling pathways.
 
Introduction
 
The plasma membrane of most cell types contains special-
ized subdomains with distinct lipid and protein composi-
tions, referred to as lipid raft microdomains (Brown and
London, 1998; Kurzchalia and Parton, 1999). The selective
inclusion or exclusion of key signaling molecules within
lipid rafts may be one means of organizing the multitude of
signals impinging on the cell surface into distinct signaling
cascades (Anderson, 1998; Okamoto et al., 1998). Indeed,
many members of the growth factor receptor superfamily
share common intracellular signaling pathways, yet produce
distinct biological responses. Spatial compartmentalization
at the plasma membrane has been suggested as a possible
means for preserving signaling specificity and fidelity in
these cases (Smart et al., 1999; Sternberg and Schmid,
1999). One such growth factor receptor is the insulin recep-
tor, which has been reported to phosphorylate and partially
colocalize with caveolin (Mastick et al., 1995; Mastick and
Saltiel, 1997; Yamamoto et al., 1998; Gustavsson et al.,
1999; Nystrom et al., 1999), the major structural compo-
nent of a subset of lipid raft microdomains that forms character-
istic invaginations of the plasma membrane termed caveolae
(Brown and London, 1998; Fujimoto et al., 1998).
Of the many functions of insulin, one of the most important
is to increase glucose uptake in striated muscle and adipose
tissues (Czech, 1995; Summers et al., 1999). In the basal
state, the insulin-responsive glucose transporter (GLUT)4*
cycles slowly between the plasma membrane and one or
more intracellular compartments, with the vast majority of
the transporter residing within the cell interior (Martin et
al., 1996a; Millar et al., 1999; Simpson et al., 2001). Insulin
triggers a large increase in the rate of GLUT4 vesicle exocy-
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tosis, resulting in the accumulation of the transporter on the
cell surface and a concomitant increase in glucose uptake
(Rea and James, 1997; Pessin et al., 1999).
It has been well established that phosphatidylinositol 3
(PI-3) kinase activity is necessary for insulin-stimulated
GLUT4 translocation (Cheatham et al., 1994; Okada et al.,
1994; Martin et al., 1996b; Sharma et al., 1998; Czech,
2000). However, a clear demonstration for a sufficient role
for PI-3 kinase has not been forthcoming. Moreover, several
lines of evidence suggest that one or more PI-3 kinase–inde-
pendent signals may be required for insulin-stimulated
GLUT4 translocation. For example, two naturally occurring
insulin receptor mutations were unable to induce GLUT4
translocation and glucose uptake, yet were fully capable of
activating PI-3 kinase (Krook et al., 1997). Activation of
PI-3 kinase activity through the interleukin 4 receptor or en-
gagement of integrin receptors also failed to enhance glucose
uptake and GLUT4 translocation (Isakoff et al., 1995; Guil-
herme and Czech, 1998). Furthermore, a cell-permeable
PI(3,4,5)P3 analogue had no effect on glucose uptake (Jiang
et al., 1998). Together, these data suggest that additional in-
sulin signaling pathways may exist that function indepen-
dently of the pathway defined by the PI-3 kinase.
The Cbl protooncogene is specifically tyrosine phosphory-
lated by the insulin receptor in adipocytes through the
adapter proteins Cbl-associated protein (CAP) and APS (Ri-
bon et al., 1998; Ahmed et al., 2000). CAP directly interacts
with Cbl and appears to be important in insulin signaling,
since expression of a dominant-interfering CAP mutant
(CAP
 

 
SH3) markedly inhibited insulin-stimulated glucose
uptake and GLUT4 translocation (Baumann et al., 2000).
More recently, we have observed that the CAP/Cbl pathway
is necessary for the activation of TC10, a Rho family GTP-
ase that is highly expressed in muscle and adipose tissues
(Neudauer et al., 1998; Imagawa et al., 1999; Chiang et al.,
2001). Here we demonstrate that TC10 localizes to caveo-
lin-enriched lipid microdomains at the plasma membrane.
Furthermore, the compartmentalization of TC10 within
lipid microdomains is essential for insulin-dependent activa-
tion of TC10 and GLUT4 translocation. These data provide
a molecular basis for the specificity of insulin signaling with
respect to glucose transport.
 
Results
 
TC10 traffics through secretory membrane 
compartments en route to the plasma membrane
 
To examine the mechanism by which TC10 modulates in-
sulin signaling and GLUT4 translocation, we first colabeled
expressed hemagglutinin (HA)-tagged TC10 with various
intracellular markers in 3T3L1 adipocytes (Fig. 1).
 
 
 
In addi-
tion, we capitalized on the differential effects of brefeldin A
(BFA) and nocodazole on endomembrane compartments to
further define the TC10 localization pattern. BFA causes the
Golgi stacks to collapse into the endoplasmic reticulum and
the TGN to coalesce with endosomal membranes in the mi-
crotubule-organizing center (Banting and Ponnambalam,
1997; Chardin and McCormick, 1999). In contrast, the mi-
crotubule inhibitor nocodazole disrupts the Golgi apparatus
into ministacks and blocks retrograde traffic between the
Golgi membranes and the endoplasmic reticulum, without
inhibiting anterograde traffic to the plasma membrane (Lip-
pincott-Schwartz et al., 1990; Kok et al., 1992).
In control cells, the cis-Golgi marker p115 showed the
characteristic perinuclear distribution (Fig. 1 A, a). The ex-
pressed TC10 protein was localized to the plasma membrane
and the perinuclear region that partially overlapped with
p115 (Fig. 1 A, b and c). BFA treatment resulted in a dis-
persed labeling pattern for p115 (Fig. 1 A, d). However,
TC10 displayed a persistent, concentrated labeling pattern
in the presence of BFA that no longer colocalized with p115
(Fig. 1 A, e and f). Similarly, disruption of the Golgi stacks
with nocodazole resulted in a dispersed labeling pattern for
p115 and the default accumulation of TC10 at the plasma
membrane (Fig. 1 A, g and h). Under these conditions, there
was also no colocalization of TC10 with p115, indicating
that the majority of the perinuclear TC10 was not localized
in the cis-Golgi (Fig. 1 A, g–i).
Syntaxin 6 is a resident protein of the TGN (Bock et al.,
1996; Watson and Pessin, 2000). In contrast to the results
obtained above with p115, TC10 showed substantial perinu-
clear overlap with syntaxin 6 in both control cells and in cells
treated with BFA (Fig. 1 B, a–f). Nocodazole treatment re-
sulted in a punctate distribution of syntaxin 6 and the accu-
mulation of TC10 at the cell surface (Fig. 1 B, g–i). The
transferrin receptor (TfR) cycles between the cell surface and
endosome compartments, where it often shows strong peri-
nuclear labeling (Fig. 1 C, a). In control and BFA-treated
cells, TfR also displayed a strong overlap with TC10 (Fig. 1
C, a–f). As described above, in the presence of nocodazole
TC10 was found predominantly at the plasma membrane,
where it overlapped with TfR (Fig. 1 C, g–i). Together, these
results indicate that TC10 is largely present in the plasma
membrane and the perinuclear-recycling endosome compart-
ment, although we can not unambiguously distinguish be-
tween recycling endosomes and the TGN in adipocytes.
Since TC10 is predicted to be both farnesylated and
palmitoylated at the COOH-terminus (Fig. 2 A), TC10
most likely transits through the secretory membrane system
en route to the plasma membrane, in an identical manner to
that established for H-Ras and several other
 
 
 
proteins that
undergo posttranslational prenylation and palmitoylation
(Choy et al., 1999; Resh, 1999; Apolloni et al., 2000;
Michaelson et al., 2001). Indeed, the TC10 expression pat-
tern was essentially indistinguishable from the subcellular
distribution of H-Ras, both in control cells and cells treated
with BFA or nocodazole (Fig. 1 D, a–i). Furthermore, incu-
bation of cells with cycloheximide subsequent to transfec-
tion resulted in the rapid and identical chase (
 

 
4 h) of the
entire endomembrane pool of both H-Ras and TC10 to the
plasma membrane (data not shown). Thus, TC10 appears to
be processed through the secretory membrane system and
perinuclear–recycling endosomes during its transit to the
plasma membrane in a manner similar to that described re-
cently for H-Ras (Prior and Hancock, 2001).
 
TC10 is functionally restricted by COOH-terminal 
targeting sequences
 
Recent studies have documented that the COOH-terminal
domains of the small GTP binding proteins of the Ras and
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Rho families direct different intracellular trafficking routes
and plasma membrane subdomain compartmentalization
(Choy et al., 1999; Roy et al., 1999; Apolloni et al., 2000;
Michaelson et al., 2001). In contrast to the trafficking and
localization of H-Ras to caveolin-enriched plasma membrane
microdomains, K-Ras is excluded from the secretory mem-
brane system and inserts into nonlipid raft domains of the
plasma membrane. Moreover, even though H-Ras and K-Ras
contain identical effector domains, this microdomain local-
ization appears to account for the different signaling proper-
ties of H-Ras compared with K-Ras (Roy et al., 1999; Walsh
and Bar-Sagi, 2001). Inspection of the COOH-terminal se-
quences indicates that TC10 should undergo posttransla-
tional modifications similar to H-Ras, which has cysteine
residues in the appropriate contexts for both farnesylation
and palmitoylation (Fig. 2 A). Therefore, to examine the role
of the COOH-terminus in the localization of TC10, we gen-
erated chimeric TC10 proteins containing the COOH-ter-
minal domains of H-Ras (TC10/H-Ras) and K-Ras (TC10/
K-Ras). As typically observed, wild-type TC10 displayed
both perinuclear and plasma membrane localization identical
to H-Ras (Fig. 2 B, a and b). In contrast, K-Ras exclusively
localized to the plasma membrane with very low levels de-
tectable in any intracellular compartment (Fig. 2 B, c). As ex-
pected, the TC10/H-Ras chimera was distributed in a man-
ner indistinguishable from both wild-type TC10 and H-Ras,
whereas the TC10/K-Ras chimera was distributed in a man-
ner indistinguishable from K-Ras (Fig. 2 B, d and e).
Figure 1. Expressed TC10 localizes to the plasma membrane and a subset of endomembrane compartments in 3T3L1 adipocytes. (A) Dif-
ferentiated 3T3L1 adipocytes were electroporated with 50 g of the cDNA encoding for the full length TC10 protein containing an NH2-
terminal HA-epitope tag as described in Materials and methods. 18 h later, the cells were either left untreated (a–c) or incubated with 10 M 
BFA (d–f) for 60 min or 33 M nocodazole (g–i) for 3 h at 37C. The cells were then fixed and colabeled with a polyclonal HA antibody (b, e, 
and h) and either (A) monoclonal antibody for p115 (a, d, and g), (B) monoclonal antibody for syntaxin 6 (a, d, and g), or (C) monoclonal 
antibody for TfR (a, d, and g). (D) The cells were cotransfected with HA-HRas (50 g) and Myc-TC10 (50 g) and treated as described above. 
The cells were then labeled with a polyclonal HA antibody (a, d, and g) and a monoclonal Myc antibody (b, e, and h). The merged images for 
each individual condition are presented in c, f, and i. These are representative cells from three independent determinations. Bar, 10 M.
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To determine whether the inhibitory property of TC10
was dependent on subdomain compartmentalization, we
next cotransfected the TC10/H-Ras or TC10/K-Ras chi-
meras with GLUT4-EGFP. Insulin stimulation resulted in
the appearance of a strong plasma membrane GLUT4-
EGFP rim fluorescence, indicative of translocation (Fig. 2
C, a and b). Similar to our previous findings, coexpression
of wild-type TC10 strongly inhibited GLUT4 transloca-
tion, whereas H-Ras and K-Ras were without any signifi-
cant effect (Fig. 2 C, c–h). Although the TC10/H-Ras
chimera potently inhibited GLUT4-EGFP translocation
in a manner identical to wild-type TC10, the TC10/K-Ras
chimera behaved like K-Ras and had no effect on GLUT4-
EGFP translocation (Fig. 2 C, i–l). These data were
quantitated by determining the number of cells display-
ing a continuous cell surface GLUT4-EGFP fluorescence
(Fig. 2 D).
We next determined whether TC10 subdomain compart-
mentalization was important for its activation by insulin
(Fig. 3). Using a GST-Pak1 pull down assay to precipitate
the GTP-bound TC10 protein, we observed that insulin
produced a time-dependent activation of the expressed wild-
type TC10 protein (Fig. 3 A, lanes 1–5). Similarly, insulin
activated the TC10/H-Ras chimera over the same time frame
(Fig. 3 B, lanes 1–5). However, insulin was unable to activate
the TC10/K-Ras chimera under the identical conditions
(Fig. 3 C, lanes 1–5). In parallel, immunoblots of cell lysates
demonstrated equal amounts of TC10 expression under all
these conditions. Quantitation of these data demonstrated
that insulin activated TC10/WT and TC10/H-Ras 1.7 
 

 
0.4- and 1.7 
 

 
 0.3-fold, respectively. In contrast, TC10/
K-Ras was not significantly activated by insulin (0.9 
 

 
 0.1).
Thus, these data demonstrate that the upstream pathway re-
quired for insulin-dependent activation of TC10 is also con-
Figure 2. The endomembrane traffick-
ing and plasma membrane subdomain 
compartmentalization of TC10 is 
defined by the COOH-terminal domain. 
(A) Amino acid sequence comparison 
of the COOH-terminal 22 amino acids 
of TC10, H-Ras, K-Ras, TC10/H-Ras 
chimera, and TC10/K-Ras chimera. (B) 
Differentiated 3T3L1 adipocytes were 
electroporated with 50 g of the HA 
epitope–tagged TC10 (a), H-Ras (b), 
K-Ras (c), TC10/H-Ras chimera (d), and 
TC10/K-Ras chimera (e) cDNAs as de-
scribed in Materials and methods. 18 h 
later, the cells were fixed and the sub-
cellular localization was determined by 
confocal fluorescent microscopy. (C) 
Differentiated 3T3L1 adipocytes were 
coelectroporated with 50 g of GLUT4-
EGFP plus 200 g of the empty vector 
(a and b), TC10 (c and d), H-Ras (e and 
f), K-Ras (g and h), TC10/H-Ras chimera 
(i and j), and TC10/K-Ras chimera 
(k and l) cDNAs. 18 h later, the cells 
were then incubated for 30 min in the 
absence (a, c, e, g, i, and k) or presence 
(b, d, f, h, j, and l) of 100 nM insulin. 
The cells were then fixed and the sub-
cellular localization was determined by 
confocal fluorescent microscopy. These 
are a representative field of cells from 
five or six independent determinations. 
(D) Quantitation of the number of cells 
displaying GLUT4-EGFP plasma mem-
brane fluorescent was determined from 
the counting of 175–200 cells that were 
coexpressing both the TC10 constructs 
and GLUT4-EGFP in five or six inde-
pendent experiments. Bar, 10 M.
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fined to the same specific lipid raft microdomain defined by
the COOH-terminal H-Ras and TC10 targeting sequences.
 
TC10 is localized to caveolae-enriched plasma 
membrane microdomains
 
To determine whether the endogenous TC10 protein was
localized to plasma membrane lipid raft microdomains, ad-
ipocytes were first colabeled with monoclonal caveolin and
polyclonal TC10 antibodies. In intact cells, the endoge-
nous TC10 protein was predominantly confined to the
plasma membrane with very little detectable expression on
intracellular membranes (Fig. 4, a and c). Similarly, caveo-
lin displayed strong plasma membrane localization with
lower, but still detectable, levels in the perinuclear region
(Fig. 4, b and c). We also prepared plasma membrane
sheets and examined the localization patterns of TC10 and
caveolin. Although individual caveolae (50–80 nm) are too
small to be detected by laser confocal microscopy, caveolae
can form large clusters or torus-shaped structures in adipo-
cytes (Gustavsson et al., 1999). Endogenous TC10 was
found to colocalize exceptionally well with caveolin in
these distinct ring-like domains at the plasma membrane
(Fig. 4, d–f).
The organization of the large, caveolin-positive structures
was examined at higher magnification (Fig. 5 A, a and b).
These torus-shaped configurations were found to range in
size from 0.5 to 1.5 
 

 
m. The assembly of individual caveo-
lae into these ringed structures was confirmed by caveolin-
immunogold electron microscopy (Fig. 5 B, a and b). At low
magnification, both individual and multiple aggregates of
immunopositive caveolin–labeled structures were present in
the adipocyte plasma membrane (Fig. 5 B, a). At higher
magnification, these aggregates of caveolin-positive struc-
tures were clearly visualized as clusters of individual immu-
nopositive caveolae organized into ring-like shapes. Further-
more, the size distribution of these aggregates were in
excellent agreement with the dimensions determined by
confocal fluorescent microscopy.
The morphological effects of cholesterol extraction on
these caveolin-positive structures were examined in Fig. 6.
Previous studies have demonstrated that treatment of cells
Figure 4. Endogenous TC10 colocal-
izes with caveolin-positive structures in 
the adipocyte plasma membrane. Differ-
entiated 3T3L1 adipocytes were left 
untreated and either the intact cells were 
directly fixed (a–c), or used to isolated 
plasma membrane sheets (d–f) as 
described in Materials and methods. The 
samples were then colabeled with a 
polyclonal TC10 antibody (a and b) 
and a monoclonal caveolin 1 antibody 
(b and e) and subjected confocal fluores-
cent microscopy. The merged images 
are presented in panels c and f. These 
are representative fields from three inde-
pendent determinations. Bar, 10 M.
Figure 3. Insulin activates TC10 only 
when specifically targeted by the TC10 
and H-Ras COOH-terminal domains. 
Differentiated 3T3L1 adipocytes were 
electroporated with (A) 50 g of HA-
TC10/WT, (B) HA-TC10/H-Ras chimera, 
and (C) HA-TC10/K-Ras chimera cDNAs 
as described in Materials and methods. 
48 h later, the cells were incubated in the 
absence (lane 1) or the presence of 100 
nM insulin for 1 (lane 2), 2 (lane 3), 
5 (lane 4), and 10 (lane 5) min. Cell ly-
sates were then prepared and either 
directly immunoblotted for TC10 expres-
sion (Lysate) or precipitated with 6 g of 
the GST-Pak1 Crib domain fusion. The 
precipitates were then solubilized and 
immunoblotted for TC10 (GST-Pak1). 
This is a representative immunoblot from 
two to four independent determinations.
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with methyl-
 

 
-cyclodextrin (
 

 
-CD) results in cholesterol
depletion and disruption of plasma membrane caveolae
(Chang et al., 1992; Rothberg et al., 1992; Hailstones et al.,
1998; Parpal et al., 2001). Similarly, treatment of adipocytes
with 
 

 
-CD resulted in a time-dependent dissolution of these
torus-shaped caveolin structures, which was nearly complete
by 60 min (Fig. 6, a–e). In addition, treatment with 
 

 
-CD
resulted in a parallel disruption of TC10 organization and
colocalization with caveolin (Fig. 6, f–o). Thus, these data
 
demonstrate that the adipocyte plasma membrane has highly
organized aggregates of individual caveolin-enriched lipid rafts
that form large morphologically distinct torus-shaped structures.
To confirm the plasma membrane compartmentalization
of the expressed TC10 and TC10/Ras chimera proteins, we
next compared their colocalization with caveolin in isolated
plasma membrane sheets. As reported previously (Li et al.,
1996; Mineo et al., 1996; Song et al., 1996; Roy et al.,
1999), H-Ras was found to colocalize with the caveolin-pos-
Figure 5. Individual plasma membrane 
caveolae are clustered into higher-order 
structures in adipocytes. (A) Plasma 
membrane sheets were prepared from 
differentiated 3T3L1 adipocytes, incu-
bated with a monoclonal caveolin 1 
antibody, and subjected to confocal fluo-
rescent microscopy at low magnification 
(a) or at high magnification (b) as indi-
cated by the inset bar. (B) Plasma mem-
brane sheets were prepared, fixed, and 
incubated with a monoclonal caveolin 1 
antibody and a 10-nm gold-conjugated 
rabbit anti–mouse antibody as described 
in Materials and methods. The samples 
where then sectioned and visualized at 
low magnification (a) or high magnifica-
tion (b) as indicated by the inset bar. 
Arrowheads indicate caveolae clustered 
into ring-shaped structures and arrows 
indicate individual caveolae.
Figure 6. Cholesterol depletion with methyl--cyclodextrin disrupts the plasma membrane subdomain compartmentalization of caveolin 
and TC10. Differentiated 3T3L1 adipocytes were incubated with 10 mM -CD for the times indicated. Plasma membrane sheets were pre-
pared and colabeled with a rabbit caveolin 1 antibody (a–e) and a chicken TC10 antibody (f–j). Merged images are presented in panels k–o. 
These are representative plasma membrane sheets from two independent determinations. Bar, 10 M.
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itive torus-shaped structures, whereas K-Ras was uniformly
distributed across the plasma membrane sheets and did not
specifically colocalize with caveolin (data not shown). As ob-
served for the endogenous TC10 protein, the expressed
TC10/WT protein was strongly colocalized with caveolin in
the torus-shaped structures (Fig. 7, a–c). A similar plasma
membrane distribution was detected for the expressed
TC10/H-Ras chimera (Fig. 7, d–f). In contrast, the TC10/
K-Ras chimera was found to be uniformly scattered through-
out the plasma membrane (Fig. 7, g–i).
 
Disruption of lipid raft microdomains with a
dominant-interfering caveolin mutant (Cav3/DGV) 
mislocalizes TC10 and inhibits GLUT4 translocation
 
A dominant-interfering caveolin 3 mutant (Cav3/DGV) has
been found to sequester cholesterol away from the endoge-
Figure 7. The expressed TC10/WT and 
TC10/H-Ras chimeras specifically colo-
calize with caveolin. Differentiated 
3T3L1 adipocytes were electroporated 
with 50 g of HA epitope–tagged TC10 
(a–c), TC10/H-Ras chimera (d–f), and 
TC10/K-Ras chimera (g–i) cDNAs, and 
plasma membrane sheets were prepared 
18 h later. The plasma membrane sheets 
were then colabeled with a polyclonal 
caveolin 1 antibody (a, d, and g) and a 
monoclonal HA antibody (b, e, and h). 
Merged images are presented in panels 
c, f, and i. These are representative 
plasma membrane sheets from three 
independent determinations.
Figure 8. Expression of a dominant- 
interfering caveolin 3 mutant disrupts 
the plasma membrane subdomain 
compartmentalization of TC10. Differ-
entiated 3T3L1 adipocytes were coelec-
troporated with 50 g of HA-TC10 plus 
200 g of the empty vector (a–c), wild-
type caveolin 3 (Cav3/WT; d–f), or the 
dominant-interfering caveolin 3 mutant 
(Cav3/DGV; g–i). 36 h later, the cells 
were fixed, plasma membrane sheets 
were prepared and subjected to confocal 
fluorescent microscopy with a polyclonal 
caveolin 1 antibody (a, d, and g), and a 
monoclonal HA antibody (b, e, and h). 
The merged images are shown in panels 
c, f, and i. These are representative field 
of cells from two independent determi-
nations. Bar, 10 M.
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nous lipid raft microdomains (Roy et al., 1999; Pol et al.,
2001). Furthermore, expression of the Cav3/DGV mutant
partially misdirected H-Ras out of membrane microdomains
and functionally inhibited H-Ras, but not K-Ras, signaling
responses (Roy et al., 1999). Since TC10 localizes to caveo-
lar structures and shows a trafficking pattern indistinguish-
able from H-Ras, we determined whether the Cav3/DGV
mutant would also effect the plasma membrane micro-
domain distribution of TC10. Similar to the endogenous
TC10 protein, the expressed EGFP-TC10/WT fusion pro-
tein was colocalized with endogenous plasma membrane ca-
veolin in the torus-shaped structures (Fig. 8, a–c). Similarly,
expression of Cav3/WT had no significant effect on the
plasma membrane microdomain localization of either the
coexpressed EGFP-TC10 protein or on endogenous caveo-
lin (Fig. 8, d–f). In contrast, expression of Cav3/DGV re-
sulted in a partial dispersion of caveolin concomitant with a
marked reduction in the number of torus-shaped caveolin-
positive structures (Fig. 8 g). More importantly, there was a
near complete scattering of TC10 throughout the plasma
membrane (Fig. 8, h and i). The greater effect of Cav3/
DGV on TC10 compared with caveolin parallels the effect
of Cav3/DGV on the plasma membrane microdomain dis-
tribution of caveolin and H-Ras reported previously for fi-
broblasts (Roy et al., 1999). In any case, the ability of Cav3/
DGV to disrupt the plasma membrane organization of
Figure 9. Expression of a dominant-
interfering caveolin 3 mutant inhibits 
insulin-stimulated GLUT4 transloca-
tion. (A) Differentiated 3T3L1 adipo-
cytes were coelectroporated with 50 g 
of GLUT4-EGFP plus 200 g of the 
empty vector (a and b), Myc epitope–
tagged wild-type caveolin 3 (Cav3/WT; 
c and d), or Myc epitope tagged domi-
nant-interfering caveolin 3 mutant 
(Cav3/DGV; e and f). 36 h later, the cells 
were then incubated for 30 min in the 
absence (a, c, and e) or presence (b, d, 
and f) of 100 nM insulin. The cells were 
then fixed and the subcellular localiza-
tion of GLUT4-EGFP was determined by 
confocal fluorescent microscopy. These 
are a representative field of cells from 
four independent determinations. (B) 
The subcellular distribution of expressed 
Cav3/WT (a and b) or the Cav3/DGV 
mutant (c and d) was determined by 
confocal fluorescent microscopy. These 
are a representative field of cells from 
four independent determinations. 
Bar, 10 M.
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TC10 is consistent with the effect of 
 

 
-CD and further sup-
ports the specific plasma membrane microdomain compart-
mentalization of TC10.
Based on these results, we next examined the effect of
Cav3/DGV on insulin-stimulated GLUT4 translocation (Fig.
9). Expression of the wild-type caveolin 3 protein (Cav3/
WT) had no effect on GLUT4-EGFP translocation, which
was essentially identical to the control transfected cells (Fig.
9 A, a–d). In contrast, the Cav3/DGV mutant inhibited in-
sulin-stimulated GLUT4-EGFP translocation (Fig. 9 A, e
and f). The expression patterns of the Cav3/WT and Cav3/
DGV constructs were also determined (Fig. 9 B). As re-
ported previously, Cav3/WT was predominantly localized to
the plasma membrane, with a small amount also present in
the perinuclear region (Fig. 9 B, a and b). In contrast, Cav3/
DGV showed strong labeling in the cytoplasm, where it
formed distinct vesicle structures (Fig. 9 B, c and d) similar
to the cholesterol-enriched vesicles previously reported in fi-
broblasts (Roy et al., 1999; Pol et al., 2001). Insulin stimula-
tion had no significant effect on the localization of either
Cav3/WT or Cav3/DGV (Fig. 9 B, a–d).
Since the insulin activation of TC10 requires the appropri-
ate COOH-terminal domain targeting sequences (Fig. 3), we
next determined the effect of Cav3/DGV on insulin-stimu-
lated TC10 activation (Fig. 10). Coexpression of HA-TC10/
WT with Cav3/WT had no significant effect on the insulin
stimulation of TC10 activation (Fig. 10 A, lanes 1–5). In con-
trast, expression of Cav3/DGV resulted in marked inhibition
in the time and extent of insulin-stimulated TC10 activation
(Fig. 10 B, lanes 1–5). Quantitation of these data demon-
strated that the maximum insulin-stimulated activation of
TC10/WT in the Cav3/WT expressing cells was 1.6 
 

 
 0.3-
fold. However, in the presence of Cav3/DGV insulin was
only able to activate TC10 1.0 
 

 
 0.1-fold. The effect of
 
Cav3/DGV was specific for TC10 activation, as there was no
detectable effect on insulin-stimulated insulin receptor auto-
phosphorylation, IRS tyrosine phosphorylation, PI(3,4,5)P3
production, or PKB/Akt activation (data not shown).
 
Discussion
 
Emerging evidence has begun to elucidate a novel insulin re-
ceptor–signaling cascade that functions in concert with, but
independent of, the PI-3 kinase pathway mediating the
translocation of intracellular GLUT4 storage compartments
to the cell surface. In adipocytes, this pathway involves the
insulin receptor–dependent tyrosine phosphorylation of Cbl
and its recruitment to lipid raft domains through the adap-
tor proteins CAP, APS, and flotillin (Moodie et al., 1999;
Ahmed et al., 2000; Baumann et al., 2000). In turn, the ty-
rosine-phosphorylated Cbl protein recruits the guanylnucle-
otide exchange factor (GEF) C3G through the small adaptor
protein CrkII (Baumann et al., 2000; Chiang et al., 2001).
Importantly, C3G can function as a GEF for the small
GTP-binding protein TC10, and insulin stimulation con-
verts TC10 from the inactive GDP-bound to the active
GTP-bound state. Furthermore, overexpression of TC10
specifically inhibits insulin-stimulated GLUT4 translocation
without any effect on other insulin-responsive vesicular
compartments. Thus, we speculated that the apparent func-
tion of the insulin-dependent assembly and plasma mem-
brane lipid raft microdomain targeting of the CAP–Cbl–
CrkII–C3G signaling complex was to direct C3G to the ap-
propriate location for efficient activation of TC10.
Although the Switch I and Switch II domains of TC10
have a high degree of sequence similarity with Rac, Rho, and
Cdc42, in other respects TC10 is an unusual member of the
Rho protein family. In particular, most Rho family members
contain a single COOH cysteine residue in the appropriate se-
quence context for geranylgeranylation and interact with gua-
nylnucleotide dissociation inhibitors (Nobes and Hall, 1995;
Bar-Sagi and Hall, 2000). In contrast, the COOH-terminal
region of TC10 contains sequences similar to that of H-Ras,
encoding for both farnesylation and palmitoylation (Hancock
et al., 1989; Seabra, 1998). Recent studies have established
that these COOH-terminal posttranslational modifications
provide key trafficking determinants that may underlie signal-
ing specificity (Sternberg and Schmid, 1999). For example,
after farnesylation, proteolytic trimming, and carboxylmethy-
lation, the subsequent palmitoylation of H-Ras allows for its
insertion and trafficking through the secretory membrane sys-
tem (Choy et al., 1999; Apolloni et al., 2000). This trafficking
pattern ultimately results in the specific targeting of H-Ras to
the caveolin-enriched plasma membrane microdomains (Du-
pree et al., 1993; Li et al., 1996; Song et al., 1996). In con-
trast, COOH-terminal K-Ras sequence does not contain any
upstream palmitoylated cysteines, but instead has a polybasic
motif that prevents its interaction with the Golgi apparatus
and directs its association with the noncaveolin regions of the
plasma membrane (Hancock et al., 1990; Choy et al., 1999;
Roy et al., 1999; Apolloni et al., 2000).
The data presented here demonstrate that TC10 traffics in
a manner analogous to that of H-Ras. Like H-Ras, TC10
Figure 10. Expression of a dominant-interfering caveolin 3 mutant 
inhibits insulin-stimulated TC10 activation. Differentiated 3T3L1 
adipocytes were electroporated with 50 g of HA-TC10/WT cDNA 
plus 200 g of Cav3/WT (A) or Cav3/DGV (B) cDNAs. 48 h later, 
the cells were incubated in the absence (lane 1) or the presence of 
100 nM insulin for 1 (lane 2), 2 (lane 3), 5 (lane 4), and 10 (lane 5) 
min. Cell lysates were then prepared and either directly immuno-
blotted for TC10 expression (Lysate) or precipitated with 6 g of the 
GST-Pak1 CRIB domain fusion. The precipitates were then solubilized 
and immunoblotted for TC10 (GST-Pak1). This is a representative im-
munoblot from three independent determinations.
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appears to transiently associate with the secretory membrane
system while en route to the plasma membrane and cycle
through the perinuclear-recycling endosome compartment.
This was based on the ability of cycloheximide to efficiently
chase TC10 out of the endomembrane system, the strong
colocalization of TC10 with the transferrin receptor, and the
complete loss of perinuclear localization in the presence of
nocodazole. It should be noted that the apparent absence of
TC10 in the perinuclear region after nocodazole treatment
could reflect either a rapid exit out of the Golgi apparatus or
the presence of an alternative trafficking pathway to the
plasma membrane, as has been reported for Ras2 in yeast
(Bartels et al., 1999). Nevertheless, in adipocytes, TC10 and
H-Ras displayed indistinguishable intracellular distributions
and trafficking patterns that are similar to that recently re-
ported for TC10 in fibroblasts (Michaelson et al., 2001).
At present, the downstream effector proteins that link ac-
tivated TC10 with GLUT4 translocation remain undefined.
Nevertheless, the data presented here clearly demonstrate
that the specific COOH-terminal targeting sequences of
TC10 are essential for the insulin-dependent activation of
TC10 and regulation of GLUT4 translocation. Indeed, chi-
meric proteins in which the 19 COOH-terminal residues of
TC10 were replaced with the corresponding amino acids
from H-Ras (TC10/H-Ras) resulted in functional targeting
in terms of insulin-stimulated TC10 activation and inhibi-
tion of GLUT4 translocation. In contrast, the correspond-
ing TC10/K-Ras chimera was completely refractory to insu-
lin stimulation and had no significant inhibitory effect on
GLUT4 translocation. Although we cannot completely rule
out the possibility that TC10 may function within en-
domembrane structures, the ability of the TC10/H-Ras chi-
mera to recapitulate wild-type TC10 function is more con-
sistent with a model wherein TC10 operates within lipid
microdomain compartments at the plasma membrane. This
conclusion is further supported by the strong colocalization
of TC10 and the TC10/H-Ras chimera with plasma mem-
brane caveolae and the fact that the TC10/K-Ras chimera
was specifically excluded from this plasma membrane subdo-
main compartment. In addition, we have demonstrated pre-
viously that the insulin-stimulated assembly of the signaling
complex that activates TC10 is also localized to plasma
membrane lipid raft microdomains (Chiang et al., 2001).
One interesting morphological feature of the adipocyte
plasma membrane is the presence of both multiple individ-
ual caveolae and clusters of caveolae organized into large
ring-shaped structures that are visualized at both the elec-
tron microscopic and light microscopy levels (Chlapowski et
al., 1983; Severs, 1988; Voldstedlund et al., 1993; Gustavs-
son et al., 1999). Previous studies have observed that in-
sulin-stimulated glucose uptake is inhibited by 
 

 
-CD
(Gustavsson et al., 1999; Parpal et al., 2001) and our data
demonstrate clearly that these higher-order caveolin and
TC10 aggregates are sensitive to cholesterol extraction. Con-
sistent with a necessary role for lipid raft microdomains, ex-
pression of the dominant-interfering caveolin 3 mutant
(Cav3/DGV) inhibited insulin-stimulated GLUT4 translo-
cation and activation of TC10. Thus, these data demon-
strate that lipid raft compartmentalization is necessary for
TC10 function with respect to insulin-stimulated GLUT4
 
translocation. Importantly, these data also demonstrate that
the compartmentalized insulin signals leading to TC10 acti-
vation are independent from those regulating activation of
the PI-3 kinase pathway.
One issue inherent to our understanding of intracellular
signaling is the mechanism by which distinct cellular re-
sponses can result from the engagement and activation of
similar arrays of downstream effector proteins. Numerous
models have been proposed to account for this phenome-
non, including the strength of signal generation, combinato-
rial diversity of different effector subsets, and/or differences
in the temporal and spatial activation of downstream targets.
In the case of insulin action, this problem has been compli-
cated by numerous studies demonstrating a variety of signals
capable of activating the PI-3 kinase pathway, yet unable to
stimulate GLUT4 translocation or glucose transport (Weise
et al., 1995; Krook et al., 1997; Guilherme and Czech,
1998; Jiang et al., 1998). In contrast, the activation of TC10
by insulin in adipocytes is not reproduced by other growth
factors and requires the assembly of established signaling
components in a spatially restricted subcompartment of the
plasma membrane. Thus, insulin receptor signaling specific-
ity, at least for GLUT4 translocation, appears to result from
a combination of both general activation of a PI-3 kinase
signal in conjunction with a spatially restricted and cell type-
specific effector activation.
 
Materials and methods
 
Antibodies
 
The syntaxin 6, caveolin 1, caveolin 2, and p115 antibodies were pur-
chased from Transduction Laboratories.
 
 
 
The transferrin receptor, phospho-
PKB (Ser473), and HA epitope tag antibodies were obtained from Leinco
Technologies, Cell Signaling Technology, and Covance Research Products,
respectively. A rabbit TC10 polyclonal antibody was prepared against the
PASYHNVQEEWVPELKDCMP peptide sequence, which also cross-reacts
with TCL (TC10-Like), a newly characterized isoform (Vignal et al., 2000).
We also generated a chicken TC10 polyclonal antibody directed against
the CZKEEWVPELKEYAP peptide sequence. Antibodies were affinity-puri-
fied using the amino-link plus immobilization kit (Pierce Chemical Co.).
 
Cell culture and transient transfection of 3T3L1 adipocytes
 
Murine 3T3L1 preadipocytes were purchased from the American Type Tis-
sue Culture Collection. Cells were cultured in DME supplemented with 25
mM glucose and 10% calf serum at 37
 

 
C with 8% C0
 
2
 
. Cells were differen-
tiated and transfected by electroporation as described previously (Watson
and Pessin, 2000). The cells were then plated on glass coverslips and stim-
ulated with 100 nM insulin for 30 min.
 
Immunofluorescence and image analysis
 
Transfected adipocytes were washed in PBS and fixed for 15 min in 4%
paraformaldehyde containing 0.2% Triton X-100, washed in PBS, and
blocked in 5% donkey serum plus 1% BSA (both from Sigma-Aldrich) for
1 h. Primary and secondary antibodies were used at 1:100 dilutions (unless
otherwise indicated) in blocking solution and samples were mounted on
glass slides with Vectashield (Vector Laboratories). Cells were imaged us-
ing confocal fluorescence microscopy. Images were then imported into
Adobe Photoshop
 
®
 
 (Adobe Systems, Inc.) for processing and composite
files were generated.
 
Preparation and processing of plasma membrane sheets
 
Adipocyte plasma membrane sheets were prepared as described previ-
ously (Robinson et al., 1992). The membrane sheets were fixed in 2%
paraformaldehyde at room temperature for 20 min and blocked with 5%
donkey serum. Membrane sheets were incubated with rabbit polyclonal
TC10 antibody (10 
 

 
g/ml) and caveolin 2 monoclonal antibody (1:10) for
90 min at 37
 

 
C. Primary antibodies were detected with Texas red dye–con-
jugated donkey anti–mouse antibody and FITC-conjugated donkey anti–
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rabbit antibody for 2 h at room temperature. To detect expressed TC10 and
TC10/Ras chimeras in plasma membrane sheets, the electroporated cells
were plated on collagen-coated coverslips and allowed to recover for 18 h
in complete media. Cells were then osmotically swelled in hypotonic
buffer and fixed in 2% paraformaldehyde/PBS for 10 min before sonica-
tion. Membrane sheets were then processed as described above and the
expressed TC10 constructs were detected with an HA antibody (1:100)
and a caveolin 1 antibody (1:250).
 
Cholesterol extraction
 
Methyl-
 

 
-cyclodextrin was added directly to serum-free DME at a final
concentration of 10 mM and the cells were incubated at 37°C for various
times. Plasma membrane sheets were prepared as described above.
 
Electron microscopy
 
Plasma membrane sheets were prepared as described above except that
they were fixed with a combination of 4% paraformaldehyde and 0.05%
glutaraldehyde for 30 min. The samples were then incubated with a mono-
clonal caveolin 1 antibody followed by a 10-nm gold-conjugated rabbit
anti–mouse antibody. The sheets were then extensively washed and fixed
a second time with 2.5% glutaraldehyde and 0.1 M sodium cacodylate,
pH 7.2, followed by staining with 1% osmium tetraoxide, 1.5% potassium
ferrocyanide, and 0.1 M sodium cacodylate, pH 7.2. The plasma mem-
brane sheets were dehydrated by serial extracts with ethanol, embedded in
eponate-12, sliced on a microtome, and visualized by transmission elec-
tron microscopy.
 
TC10/Ras chimeric constructs and DNA cloning
 
The TC10/H-Ras and TC10/K-Ras chimeras were generated using the PCR-
based overlap extension method as described (Horton et al., 1993). In
brief, the COOH-terminal 19 amino acids of TC10 (KHTVKKRIGSRCINC-
CLIT) were replaced with either the final 19 amino acids of H-Ras (LNPP-
DESGPGCMSCKCVLS) or the final 19 amino acids of K-Ras (MSKDGKKK-
KKKSKTKCVIM). The mouse caveolin-3 cDNA was purchased from the
American Type Culture Collection and subcloned into the pcDNA3.1/
Myc-HIS vector (Invitrogen). To generate the Cav3/DGV mutant, PCR was
used to remove the NH
 
2
 
-terminal 54 amino acids from caveolin 3 (Roy et
al., 1999).
 
Affinity precipitation of TC10 using GST-Pak1/CRIB domain
 
Precipitation of activated (GTP-bound) TC10 using the GST-Pak1/CRIB do-
main fusion protein was performed as described previously (Baumann et
al., 2000). In brief, cell lysates in a volume of 100 
 

 
l were incubated for
1 h at 4
 

 
C with 200 
 

 
l of binding buffer (25 mM Tris, pH 7.5, 1 mM DTT,
30 mM MgCl
 
2
 
, 40 mM NaCl, 0.5% NP-40) in the presence of 8 g of GST-
Pak1/CRIB coupled to glutathione-Sepharose 4B beads. The beads were
then washed three times with 25 mM Tris, pH 7.5, 1 mM DTT, 30 mM
MgCl2, 40 mM NaCl, 1% NP-40 and once with the same buffer without
NP-40. The beads were suspended in 20 l Laemmli sample buffer. Pro-
teins were separated by 4–20% SDS-PAGE, transferred to nitrocellulose
membrane and blotted with a HA monoclonal antibody, and detected by
chemiluminescence (New England Nuclear).
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